Allphase Clinical Research Revenue and Competitors
Estimated Revenue & Valuation
- Allphase Clinical Research's estimated annual revenue is currently $6.8M per year.
- Allphase Clinical Research's estimated revenue per employee is $201,000
Employee Data
- Allphase Clinical Research has 34 Employees.
- Allphase Clinical Research grew their employee count by -41% last year.
Allphase Clinical Research's People
Name | Title | Email/Phone |
---|---|---|
1 | Project Manager | Reveal Email/Phone |
2 | Manager Clinical Operations | Reveal Email/Phone |
3 | Finance Manager | Reveal Email/Phone |
4 | Senior Manager, Data Management | Reveal Email/Phone |
5 | President | Reveal Email/Phone |
6 | Clinical Study Associate | Reveal Email/Phone |
Allphase Clinical Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.5M | 92 | -1% | N/A | N/A |
#2 | $14.3M | 71 | 6% | N/A | N/A |
#3 | $36M | 179 | 8% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $17.9M | 93 | 3% | $192.2M | N/A |
#6 | $64.9M | 323 | 4% | N/A | N/A |
#7 | $0.5M | 5 | -55% | N/A | N/A |
#8 | $6.8M | 34 | -41% | N/A | N/A |
#9 | $19.5M | 97 | 23% | N/A | N/A |
#10 | $2.5M | 25 | 19% | N/A | N/A |
What Is Allphase Clinical Research?
Allphase Clinical Research is a full-service clinical development company providing clinical trial management services, including regulatory affairs, project management, clinical monitoring, data management, quality assurance auditing, drug safety, and medical writing. Allphase provides Phase I to IV support throughout a wide range of therapeutic areas, with a predominant focus in oncology, CNS, and critical care diseases. Allphase provides integrative and strategic clinical trial services that allow our international partners to realize the advantages of conducting clinical trails in North America, while reinforcing therir global development cpabilities.
keywords:N/AN/A
Total Funding
34
Number of Employees
$6.8M
Revenue (est)
-41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Allphase Clinical Research News
Vidutolimod is also under study in three other clinical trials, including: CMP-001-011, a randomized Phase II/III trial (NCT04695977) comparing...
This draft guidance addresses FDA's recommendations regarding clinical trials for drugs being developed for the treatment of celiac disease...
The study is on track to complete all Phase I dosing by Q2 2022. According to PEW Charitable Trusts Global Antibiotic pipeline review, R327 is...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 34 | N/A | N/A |
#2 | $4.4M | 34 | 70% | N/A |
#3 | $6.8M | 35 | -3% | N/A |
#4 | $3.9M | 35 | 30% | $7M |
#5 | $75M | 35 | 3% | N/A |